DOI QR코드

DOI QR Code

Pulmonary Metastasectomy in Adult Patients with Synovial Sarcoma: A Single-Center Experience

  • Lee, Kanghoon (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kang, Moon Chul (Department of Thoracic and Cardiovascular Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences) ;
  • Lee, Hae Won (Department of Thoracic and Cardiovascular Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences) ;
  • Park, Jong Ho (Department of Thoracic and Cardiovascular Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences) ;
  • Baek, Hee Jong (Department of Thoracic and Cardiovascular Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences) ;
  • Cho, Sung Joon (Department of Thoracic and Cardiovascular Surgery, Kangwon National University School of Medicine) ;
  • Jeon, Dae-Geun (Department of Orthopaedic Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences)
  • Received : 2016.01.12
  • Accepted : 2016.09.12
  • Published : 2016.12.05

Abstract

Background: This study assessed the efficacy of pulmonary metastasectomy for synovial sarcoma in adult patients. Methods: Fifty patients, diagnosed with pulmonary metastasis from June 1990 to August 2010, were reviewed retrospectively. Twenty-eight patients underwent complete pulmonary metastasectomy, and their survival was evaluated. Age, sex, time to metastatic progression, laterality, number of tumors, size of largest nodule, and number of metastasectomies were analyzed as potential prognostic factors. Results: In all, 29 patients underwent at least one pulmonary metastasectomy, and 51 resections were performed. One intraoperative mortality occurred, and the 5-year survival rate was 58.4%. Bilateral metastases and early metastatic progression were associated with poor survival in multivariate analyses. Conclusion: Surgical resection can be a good option for treating pulmonary metastasis in patients with synovial sarcoma. Repeated resection was feasible with low mortality and morbidity.

Keywords

References

  1. Fisher C. Synovial sarcoma. Ann Diagn Pathol 1998;2:401-21. https://doi.org/10.1016/S1092-9134(98)80042-7
  2. Kransdorf MJ. Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. AJR Am J Roentgenol 1995;164:129-34. https://doi.org/10.2214/ajr.164.1.7998525
  3. Ferrari A, Gronchi A, Casanova M, et al. Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution. Cancer 2004;101:627-34. https://doi.org/10.1002/cncr.20386
  4. Okcu MF, Munsell M, Treuner J, et al. Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome. J Clin Oncol 2003;21:1602-11. https://doi.org/10.1200/JCO.2003.07.008
  5. Murphey MD, Gibson MS, Jennings BT, Crespo-Rodriguez AM, Fanburg-Smith J, Gajewski DA. From the archives of the AFIP: imaging of synovial sarcoma with radiologicathologic correlation. Radiographics 2006;26:1543-65. https://doi.org/10.1148/rg.265065084
  6. Singer S, Baldini EH, Demetri GD, Fletcher JA, Corson JM. Synovial sarcoma: prognostic significance of tumor size, margin of resection, and mitotic activity for survival. J Clin Oncol 1996;14:1201-8. https://doi.org/10.1200/JCO.1996.14.4.1201
  7. Stanelle EJ, Christison-Lagay ER, Wolden SL, Meyers PA, La Quaglia MP. Pulmonary metastasectomy in pediatric/adolescent patients with synovial sarcoma: an institutional review. J Pediatr Surg 2013;48:757-63. https://doi.org/10.1016/j.jpedsurg.2012.09.042
  8. Spillane AJ, A'Hern R, Judson IR, Fisher C, Thomas JM. Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment. J Clin Oncol 2000;18:3794-803. https://doi.org/10.1200/JCO.2000.18.22.3794
  9. Gadd MA, Casper ES, Woodruff JM, McCormack PM, Brennan MF. Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma. Ann Surg 1993;218:705-12. https://doi.org/10.1097/00000658-199312000-00002
  10. Billingsley KG, Burt ME, Jara E, et al. Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg 1999;229:2-10.
  11. Lanza LA, Putnam JB Jr, Benjamin RS, Roth JA. Response to chemotherapy does not predict survival after resection of sarcomatous pulmonary metastases. Ann Thorac Surg 1991;51:219-24. https://doi.org/10.1016/0003-4975(91)90789-S
  12. Predina JD, Puc MM, Bergey MR, et al. Improved survival after pulmonary metastasectomy for soft tissue sarcoma. J Thorac Oncol 2011;6:913-9. https://doi.org/10.1097/JTO.0b013e3182106f5c
  13. Spurrell EL, Fisher C, Thomas JM, Judson IR. Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital. Ann Oncol 2005;16:437-44. https://doi.org/10.1093/annonc/mdi082
  14. Song WS, Jeon DG, Park JH, et al. Long term survival of synovial sarcoma and treatment strategy. J Korean Orthop Assoc 2004;39:329-34. https://doi.org/10.4055/jkoa.2004.39.3.329
  15. Koh KH, Cho EY, Kim DW, Seo SW. Multivariate analysis of prognostic factors in synovial sarcoma. Orthopedics 2009;32:824.
  16. Hasegawa T, Yokoyama R, Matsuno Y, Shimoda T, Hirohashi S. Prognostic significance of histologic grade and nuclear expression of beta-catenin in synovial sarcoma. Hum Pathol 2001;32:257-63. https://doi.org/10.1053/hupa.2001.22764

Cited by

  1. Risk Factors Including Age, Stage and Anatomic Location that Impact the Outcomes of Patients with Synovial Sarcoma vol.6, pp.1, 2016, https://doi.org/10.3390/medsci6010021
  2. Treatment of cardiac synovial sarcoma: experience of two cases vol.13, pp.None, 2016, https://doi.org/10.1186/s13019-018-0771-0
  3. Usefulness of SS18-SSX antibody as a diagnostic marker for pulmonary metastatic synovial sarcoma vol.16, pp.1, 2016, https://doi.org/10.1186/s13000-021-01110-6